Abstract

Spinal cord stimulation (SCS) can improve limb salvage, microcirculatory blood flow, and pain relief in patients with chronic limb-threatening ischemia (CLTI) who are not suitable for revascularization or have persistent ischemic-related pain after revascularization1, 2. Candidates should be chosen based on a microcirculatory evaluation and/or a trial period with an external device3,4. Herein, we present fifteen-year safety and effectiveness outcomes using SCS for CLTI at our center.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call